معرفی
MEHMET ÖZASLAN is a Professor in the Department of Biology at Gaziantep University's Faculty of Science and Literature. With a distinguished academic career spanning over three decades, he has established himself as a prominent researcher in molecular biology, genetics, and virology. His work bridges traditional biological sciences with modern medical applications, particularly in cancer research and antimicrobial studies.
Prof. Özaslan completed his undergraduate education in Plant Protection at Çukurova University's Faculty of Agriculture (1981-1985), followed by two Master's degrees - one in Plant Protection at Çukurova University (1985-1988) and another in Molecular Biology at The Mediterranean Agronomic Institute of Bari (1986-1987). He earned his PhD in Plant Protection from Çukurova University (1988-1995). He served as an Associate Professor at Gaziantep University from 2000-2008 before being promoted to Professor in 2008, where he continues his work in the Molecular Biology Department.
His research interests focus on molecular mechanisms of disease, particularly cancer biology, antimicrobial resistance, and phytochemical applications in medicine. He has made significant contributions to understanding tumor models, DNA repair mechanisms, and the therapeutic potential of plant compounds. His work often integrates computational approaches with experimental biology, as evidenced by his numerous publications on molecular docking and genetic analysis.
An analysis of his recent publications (2023-2025) reveals a strong focus on cancer research (particularly breast cancer), antimicrobial resistance, phytochemical applications, and pandemic preparedness. His work spans multiple subfields including molecular oncology, virology, pharmacology, and computational biology, demonstrating an interdisciplinary approach that connects basic science with clinical applications.
Prof. Özaslan has been remarkably productive, with 198 listed publications spanning from 2009 to 2025. His scholarly output includes numerous articles in SCI-indexed journals, book chapters, and contributions to international publications. His research has increasingly focused on molecular mechanisms of disease, nanotechnology applications in medicine, and pandemic-related research since 2020.
His laboratory work appears to focus on tumor models (particularly Ehrlich ascites carcinoma), molecular interactions of therapeutic compounds, and genetic analysis of disease mechanisms. He frequently collaborates with researchers across Turkey and internationally, particularly with colleagues working on cancer biology, virology, and medicinal plant research.
